Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5278453
Max Phase: Preclinical
Molecular Formula: C28H24N2Na2O10S4
Molecular Weight: 678.79
Associated Items:
ID: ALA5278453
Max Phase: Preclinical
Molecular Formula: C28H24N2Na2O10S4
Molecular Weight: 678.79
Associated Items:
Canonical SMILES: Cc1ccc(S(=O)(=O)Nc2ccc(/C=C/c3ccc(NS(=O)(=O)c4ccc(C)cc4)cc3S(=O)(=O)[O-])c(S(=O)(=O)[O-])c2)cc1.[Na+].[Na+]
Standard InChI: InChI=1S/C28H26N2O10S4.2Na/c1-19-3-13-25(14-4-19)41(31,32)29-23-11-9-21(27(17-23)43(35,36)37)7-8-22-10-12-24(18-28(22)44(38,39)40)30-42(33,34)26-15-5-20(2)6-16-26;;/h3-18,29-30H,1-2H3,(H,35,36,37)(H,38,39,40);;/q;2*+1/p-2/b8-7+;;
Standard InChI Key: PRPAASSVDIZIJI-MIIBGCIDSA-L
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 678.79 | Molecular Weight (Monoisotopic): 678.0470 | AlogP: 4.57 | #Rotatable Bonds: 10 |
Polar Surface Area: 201.08 | Molecular Species: ACID | HBA: 8 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 12 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: -2.75 | CX Basic pKa: | CX LogP: 4.68 | CX LogD: -0.26 |
Aromatic Rings: 4 | Heavy Atoms: 44 | QED Weighted: 0.14 | Np Likeness Score: -0.62 |
1. Demeyer A, Fonteneau L, Liennard M, Foyer C, Weigel P, Laurent AD, Lebreton J, Fleury F, Mathé-Allainmat M.. (2023) Synthesis and biological evaluation of DIDS analogues as efficient inhibitors of RAD51 involved in homologous recombination., 87 [PMID:36990245] [10.1016/j.bmcl.2023.129261] |
Source(1):